By administering the peptide during a fasted state when insulin is low, you maximize the peptides ability to stimulate fat breakdown without metabolic interference
Ongoing studies are aimed at determining the potential relevance of NNMT inhibition to cognitive performance and neurological research
Protocol: AOD-9604 300 mcg/day, mild caloric deficit (200-300 calories), maintained training volume
Benefits of AOD-9604 Patients on AOD-9604 at IV Hub Dubai commonly report visible reduction in stubborn fat (particularly central, visceral and lower abdominal fat), preserved muscle mass through a fat-loss phase, more stable energy and reduced afternoon dips, improved metabolic flexibility, and easier maintenance of body composition after the cycle ends
The use of compounded medications involves known and unknown risks that vary from patient to patient
For patients seeing skin laxity alongside fat loss, this stack addresses both processes simultaneously